HHS Orders Gallo Forum Canceled; Meeting May Be Held After OSI report final – Calabresi
In Brief: NY Judges, Lawyers Form Breast Cancer Alert; Terms of ODAC Chairman, 3 Members Expire
Breast Cancer Vs. Other Cancers In Budget Showdown
ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin
Management Survey Finds Problems At ACS, Advises Change
Coalition On Smoking Or Health to Launch Effort at $5 Tax Increase
DCBDC Advisors Okay New Program In Breast Cancer
Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - Imaging’s ride to the bottom in clinical trials—and why it matters now
- NIH says it’s moving away from animal-based models
- The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic - ODAC nixes GSK’s Blenrep myeloma regimens, citing ocular toxicity, dosing, applicability to U.S. population